April 2012

Dr. Emma Börgeson Awarded Prestigious Marie Curie Fellowship

Wed, 25 April 12 09:00

Emma BörgesonThe Marie Curie fellowship is targeted towards the development of promising 'young' researchers (4-10 years research experience) and consists of two parts: one outgoing phase, which takes place at University of California San Diego (UCSD) for two years with Professor Kumar Sharma at UCSD, followed by the return phase which takes place at the UCD Conway Institute of Biomolecular and Biomedical Research. Research during the return phase will be undertaken under the mentorship of Professor Catherine Godson at UCD.

This innovative research and career development programme is designed to help researchers to reach a level of professional maturity in the areas of scientific research and innovation related to obesity and associated kidney disease.

Dr. Börgeson will investigate the therapeutic potential of novel lipid mediators in obesity-induced pathologic conditions such as kidney disease. The global prevalence of obesity has reached epidemic proportions and is associated with serious chronic complications including diabetes, hypertension, atherosclerosis and kidney disease.

Interestingly, there is a growing appreciation that obesity and its associated complications reflect chronic low-grade inflammation. Recent evidence highlights that the resolution of inflammation is actively regulated by endogenous pro-resolving lipid mediators, such as lipoxins (LXs) and resolvins (Rvs). Dr. Börgeson will investigate the potential of using LXs, synthetic LX-analogues and Rvs as therapeutics to subvert obesity related pathologies, placing particular focus on chronic kidney disease.

Catherine GodsonThe project will enable Dr. Börgeson to develop her career as an expert in the field of inflammation, obesity and obesity related complications, including kidney disease. The synergy between Professor Sharma (expert in obesity and chronic kidney disease) and Professor Godson (expert in inflammation and chronic kidney disease) will be vital to the success of the project.

The collaboration will provide a unique research opportunity to combine state of the art facilities and innovative in vitro, in vivo and human research methodology. On completion of the IOF project Dr. Börgeson will secure an independently funded academic position in Europe and contribute to the European biomedical research community and biotech industries.

More information about the Marie Curie Fellowship is available here.